News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Classifieds |
Employment |
Obituary |
Business
-
Briefly
Orchid gets USFDA nod for cephalexin
CHENNAI:
Orchid Chemicals & Pharmaceuticals Ltd (Orchid), on Wednesday, announced that it had received approval from the USFDA for its ANDA (abbreviated new drug application) of cephalexin capsules USP 250 mg and 500 mg. This is the first ANDA approval received by the company in the oral formulations segment in the U.S. Cephalexin is an off-patent molecule that forms part of Orchid's distribution alliance with US generic pharma major, Par Pharmaceuticals.
Printer friendly
page
Send this article to Friends by
E-Mail
Business
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Classifieds |
Employment |
Obituary |
Updates:
Breaking News |
|
